Stock Events

Stock Events

Halozyme Therapeutics (HTI) Q2 2026 Earnings

12MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-0.24

0.57

1.39

2.2

Details

Expected EPS

1.528

Actual EPS

N/A

Surprise EPS

-1.53

Surprise Percent

+100%

Description

Halozyme Therapeutics (HTI) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.